Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Int J Rheum Dis ; 20(10): 1337-1349, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26481104

RESUMO

AIM: To investigate the antinociceptive, antiedematogenic and chondroprotective effects of diacerein (DIA) in a model of joint inflammation induced by complete Freund's adjuvant (CFA), as well as to investigate the involvement of metalloproteinase (MMP)-9, transient receptor potential vanilloid 1 (TRPV1) and glial cells in DIA's action mechanism. METHODS: Complete Freund's adjuvant was injected into the knee joint of male rats. We observed mechanical and cold hypersensitivity, vocalization and spontaneous pain-related behaviors, as well as edema of the knee. Tissue samples of the knee were stained with Cason`s technique and the thickness of the condilus cartilage was measured. Immunohistochemical analysis was performed on the spinal cord using anti-GFAP (glial fibrillary acidic protein), anti-MMP and anti-TRPV1 antibodies. Sections of the dorsal horns of the spinal cord were captured and an optical density was obtained. RESULTS: Complete Freund's adjuvant induced mechanical and thermal hypersensitivity, as well as joint edema and changes in the synovial membrane and cartilage. DIA (30 mg/kg, orally, daily) significantly inhibited mechanical (58 ± 10-87 ± 3%) and thermal (66 ± 12-87 ± 8%) hypersensitivity, vocalization (83 ± 5-41 ± 11%), spontaneous pain score, joint swelling (60 ± 6-40 ± 9%), as well as the histological changes induced by CFA. In addition, DIA inhibited astrocyte activation, and prevented the increase of MMP-9 and TRPV1 expression in the spinal cord of the animals subjected to CFA injections. CONCLUSIONS: In short, this study shows that DIA reduces joint damage and hypersensitivity associated with inflammation induced by CFA through the inhibition of astroglial activation and decreases the expression of TRPV1 and MMP-9 in the rat spinal cord.


Assuntos
Analgésicos/farmacologia , Antraquinonas/farmacologia , Antirreumáticos/farmacologia , Artrite Experimental/prevenção & controle , Comportamento Animal/efeitos dos fármacos , Articulações/efeitos dos fármacos , Metaloproteinase 9 da Matriz/metabolismo , Inibidores de Metaloproteinases de Matriz/farmacologia , Neuroglia/efeitos dos fármacos , Medula Espinal/efeitos dos fármacos , Canais de Cátion TRPV/antagonistas & inibidores , Animais , Artrite Experimental/enzimologia , Artrite Experimental/patologia , Artrite Experimental/psicologia , Edema/enzimologia , Edema/patologia , Edema/prevenção & controle , Adjuvante de Freund , Articulações/patologia , Masculino , Neuroglia/enzimologia , Neuroglia/patologia , Dor Nociceptiva/induzido quimicamente , Dor Nociceptiva/enzimologia , Dor Nociceptiva/patologia , Dor Nociceptiva/psicologia , Ratos Wistar , Medula Espinal/enzimologia , Medula Espinal/patologia , Medula Espinal/fisiopatologia , Canais de Cátion TRPV/metabolismo , Sensação Térmica/efeitos dos fármacos , Fatores de Tempo , Vocalização Animal/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA